Lipoprotein lipase gene polymorphism and lipid profile in coronary artery disease

被引:0
|
作者
Duman, BS
Türkoglu, C
Akpinar, B
Güden, M
Vertii, A
Dak, E
Çagatay, P
Günay, D
Büyükdevrim, AS
机构
[1] Kadir Has Univ, Sch Med, Dept Med Biol & Genet, TR-80810 Istanbul, Turkey
[2] Kadir Has Univ, Sch Med, Dept Cardiol, TR-80810 Istanbul, Turkey
[3] Kadir Has Univ, Sch Med, Dept Heart & Vasc Surg, TR-80810 Istanbul, Turkey
[4] Istanbul Univ, Cerrahpasa Med Sch, Dept Biostat, Istanbul, Turkey
[5] Florence Nightingale Hosp, Biochem Lab, Istanbul, Turkey
[6] Florence Nightingale Hosp, Dept Diabetol & Metab Disorders, Istanbul, Turkey
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Lipoprotein lipase (LPL) plays a central role in lipid metabolism, hydrolyzing triglyceride in chylomicrons and very-low-density lipoproteins. The PvuII polymorphic variant of LPL gene is common and might affect risk of coronary artery disease (CAD). Objective.-Our aim was to determine whether LPL-PvuII polymorphism can be considered to be an independent risk factor or a predictor for CAD in Turkish subjects. Design.-We used polymerase chain reaction and restriction enzyme digestion to determine the distribution of the previously described C-->T transition that causes a PvuII polymorphism in intron 6 among healthy blood donors of Turkish origin and among angiographically confirmed CAD patients with comparable ethnic backgrounds. Results.-For the PvuII genotypes, within the CAD group (n = 80), the +/- genotype was found in 39 individuals (48.8%), whereas 25 (31.3%) carried the +/+ genotype, and 14 (17.5%) carried the -/- genotype. Within the control group (n = 49), the -/- genotype was found in 19 individuals (38.8%), 16 (32.7%) carried the +/- genotype, and 14 (28.6%) carried the +/+ genotype. The genotype frequency distribution was significantly different (P = .049) in the CAD and control study groups. The most frequent genotype among CAD patients was +/-; this genotype was more frequent in patients than in control subjects. However, the -/- genotype was more prevalent in the control group. Lipoprotein lipase-PvuII polymorphism was found to be associated with fasting total cholesterol and low-density lipoprotein cholesterol levels. The +/+ genotype was found to have higher levels of total cholesterol and low-density lipoprotein cholesterol in both the CAD and control groups. Conclusion.-There was a difference in the distribution of LPL-PvuII genotypes between the healthy subjects and the patients with CAD. Lipoprotein lipase-PvuII polymorphisms were not detected as independent risk factors for CAD in this study group, but had associations with lipid levels.
引用
收藏
页码:869 / 874
页数:6
相关论文
共 50 条
  • [31] MUTATIONS IN THE LIPOPROTEIN-LIPASE GENE IN FAMILIAL COMBINED HYPERLIPIDEMIA AND CORONARY-ARTERY DISEASE
    DEEB, SS
    YANG, WS
    NEVIN, D
    IWASAKI, L
    PENG, R
    BROWN, BG
    BRUNZELL, JD
    CIRCULATION, 1995, 92 (08) : 2351 - 2351
  • [32] Polymorphism of the goat lipoprotein lipase gene
    Badaoui, B.
    Jordana, J.
    Falagan, A.
    Serradilla, J. M.
    Amills, M.
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 2005, 141 (03): : S80 - S80
  • [33] Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease
    Zhang, Q
    Cavanna, J
    Winkelman, BR
    Shine, B
    Gross, W
    Marz, W
    Galton, DJ
    CLINICAL GENETICS, 1995, 48 (06) : 293 - 298
  • [34] Lipoprotein lipase gene haplotypes in Mexican-Americans: Structure and association with coronary artery disease
    Goodarzi, MO
    Guo, XQ
    Taylor, KD
    Quinones, M
    Yang, HY
    Samayoa, C
    Saad, MF
    Palotie, A
    Krauss, RM
    Hsueh, WA
    Rotter, JI
    CIRCULATION, 2002, 106 (19) : 754 - 754
  • [35] Common DNA polymorphisms at the lipoprotein lipase gene - Association with severity of coronary artery disease and diabetes
    Wang, XL
    McCredie, RM
    Wilcken, DEL
    CIRCULATION, 1996, 93 (07) : 1339 - 1345
  • [36] Lipid profile in patients with coronary artery disease
    Dana, P
    Zdrenghea, D
    Muste, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 115 - 115
  • [37] Lipid profile in patients with coronary artery disease
    Haddad, FH
    Omari, AA
    Shamailah, QM
    Malkawi, OM
    Shehab, AI
    Mudabber, HK
    Shubak, MK
    SAUDI MEDICAL JOURNAL, 2002, 23 (09) : 1054 - 1058
  • [38] LIPID AND LIPOPROTEIN FRACTIONS AND CORONARY-ARTERY DISEASE
    LAVIE, CJ
    MAYO CLINIC PROCEEDINGS, 1993, 68 (06) : 618 - 619
  • [39] Potentially protective effects of the Ser447-Ter mutation of the lipoprotein lipase gene against the development of coronary artery disease in Japanese subjects via a beneficial lipid profile
    Sawano, M
    Watanabe, Y
    Ohmura, H
    Shimada, K
    Daida, H
    Mokuno, H
    Yamaguchi, H
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 2001, 65 (04): : 310 - 314
  • [40] Association of apolipoprotein(A) polymorphism with lipoprotein(A) concentration in coronary artery disease
    Bogavac-Stanojevic, N.
    Jelic-Ivanovic, Z.
    Spasojevic-Kalimanovska, V.
    Topic, A.
    Spasic, S.
    Kalimanovska-Ostric, D.
    Zeljkovic, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 139 - 140